TFA
BMY.RT

Toth Financial Advisory’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Toth Financial Advisory’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-280
Closed – – 737
2020
Q4 		$0 Buy
280
+80
+40% +$170 ﹤0.01% 643
2020
Q3 		$0 Sell
200
-105
-34% -$300 ﹤0.01% 630
2020
Q2 		$1K Hold
305
– – ﹤0.01% 541
2020
Q1 		$1K Hold
305
– – ﹤0.01% 450
2019
Q4 		$1K Buy
+305
New +$793 ﹤0.01% 477

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Toth Financial Advisory's BMY.RT Position: Q1 2021 in Review

Toth Financial Advisory sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 280 shares.

Toth Financial Advisory first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Toth Financial Advisory reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Toth Financial Advisory sold 280 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Toth Financial Advisory first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Toth Financial Advisory's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Toth Financial Advisory's 13F filing for Q1 2021, filed 20 Apr 2021.